Mayne Pharma | Себестоимость

Created with Highcharts 10.1.0Chart context menu-3.32M025.4M50.7M76.1M101M127M142M
201920202021202220232024


Cost Of Sales Изменить Дата
Ansell USD 254.1M 232.2M 2024-06
Avita Medical AUD 2.28M 170K 2024-12
Cochlear AUD 269.9M 300K 2024-06
CSL USD 3.41B 315M 2024-06
Ecofibre AUD 5.55M 761K 2024-06
Healius AUD 107.9M 201.85M 2024-12
Integral Diagnostics AUD 11.53M 146K 2024-06
Medical Developments International AUD 2.35M 1.73M 2024-06
Nanosonics AUD 10.69M 5.5M 2024-06
Next Science USD 2.27M 387.28K 2024-06
Polynovo AUD 4.77M 2.77M 2024-06
Ramsay Health Care AUD 2.23B 6.3M 2024-12
ResMed USD 530.81M 23.52M 2024-12
Sigma Healthcare AUD 1.72B 188.07M 2024-07
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Telix Pharmaceuticals AUD 148.66M 10.4M 2024-12



Mayne Pharma Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.